Approval · Notice of Compliance 6434 · 2005
SENSORCAINE FORTE: Notice of Compliance 6434
Issued April 15, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6434
- Date
- April 15, 2005
- Company
- Dentsply Canada Ltd.Woodbridge, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Local anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE FORTE | 01976214 | Cancelled Post Market |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML
- EPINEPHRINE BITARTRATE 5 MCG per ML